Product Pipeline

Using its versatile, comprehensive, proprietary drug design platform, Lead Pharma has developed a pipeline of drug candidates against key targets in oncology and autoimmune diseases.


Lead Pharma has particular expertise in the development of novel chemotypes and can also address targets that evade conventional drug development strategies either because expression, production and assay development have been too complicated so far or because the ligand-binding domains are inaccessible for conventional chemotypes.


As an example, Lead Pharma has developed a novel class of compounds against nuclear receptors and transcription factors.